One of the latest trends is GLP-1 weight loss patches, which are widely sold online and promise to suppress appetite, reduce cravings, and promote fat burning
Common risk factors for coronary artery disease explain only 2550% of increased atherosclerotic risk in diabetes mellitus
This is because there is not enough safety data to know whether taking a GLP-1 medicine can cause harm to the baby. That means even if youre trying to lose weight after birth, GLP-1s are not considered safe while nursing
And it certainly does not mean you should panic, double your dose, or abandon ship
Landmark trials show semaglutide (Wegovy) produces 10-15% body weight reduction over 68 weeks, while tirzepatide achieves 20-22% reduction by targeting dual GLP-1 and GIP pathways
If you follow me, I will regularly deliver articles explaining pharmaceutical and medical topics from the perspective of data and clinical practice